372 related articles for article (PubMed ID: 35276910)
1. Maximizing the Estrogenic Potential of Soy Isoflavones through the Gut Microbiome: Implication for Cardiometabolic Health in Postmenopausal Women.
Leonard LM; Choi MS; Cross TL
Nutrients; 2022 Jan; 14(3):. PubMed ID: 35276910
[TBL] [Abstract][Full Text] [Related]
2. Equol: A Bacterial Metabolite from The Daidzein Isoflavone and Its Presumed Beneficial Health Effects.
Mayo B; Vázquez L; Flórez AB
Nutrients; 2019 Sep; 11(9):. PubMed ID: 31527435
[TBL] [Abstract][Full Text] [Related]
3. S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.
Virk-Baker MK; Barnes S; Krontiras H; Nagy TR
Nutr Res; 2014 Feb; 34(2):116-25. PubMed ID: 24461312
[TBL] [Abstract][Full Text] [Related]
4. Potential Protective Mechanisms of S-equol, a Metabolite of Soy Isoflavone by the Gut Microbiome, on Cognitive Decline and Dementia.
Sekikawa A; Wharton W; Butts B; Veliky CV; Garfein J; Li J; Goon S; Fort A; Li M; Hughes TM
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233223
[TBL] [Abstract][Full Text] [Related]
5. Effects of short-term fructooligosaccharide intake on equol production in Japanese postmenopausal women consuming soy isoflavone supplements: a pilot study.
Tousen Y; Uehara M; Abe F; Kimira Y; Ishimi Y
Nutr J; 2013 Sep; 12():127. PubMed ID: 24034304
[TBL] [Abstract][Full Text] [Related]
6. A Gnotobiotic Mouse Model with Divergent Equol-Producing Phenotypes: Potential for Determining Microbial-Driven Health Impacts of Soy Isoflavone Daidzein.
Leonard LM; Simpson AMR; Li S; Reddivari L; Cross TL
Nutrients; 2024 Apr; 16(7):. PubMed ID: 38613113
[TBL] [Abstract][Full Text] [Related]
7. Equol production capability is associated with favorable vascular function in postmenopausal women using tibolone; no effect with soy supplementation.
Törmälä R; Appt S; Clarkson TB; Groop PH; Rönnback M; Ylikorkala O; Mikkola TS
Atherosclerosis; 2008 May; 198(1):174-8. PubMed ID: 17961576
[TBL] [Abstract][Full Text] [Related]
8. Bacterial communities and metabolic activity of faecal cultures from equol producer and non-producer menopausal women under treatment with soy isoflavones.
Guadamuro L; Dohrmann AB; Tebbe CC; Mayo B; Delgado S
BMC Microbiol; 2017 Apr; 17(1):93. PubMed ID: 28415978
[TBL] [Abstract][Full Text] [Related]
9. Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: a randomized crossover trial.
Pawlowski JW; Martin BR; McCabe GP; McCabe L; Jackson GS; Peacock M; Barnes S; Weaver CM
Am J Clin Nutr; 2015 Sep; 102(3):695-703. PubMed ID: 26245807
[TBL] [Abstract][Full Text] [Related]
10. Daidzein Intake Is Associated with Equol Producing Status through an Increase in the Intestinal Bacteria Responsible for Equol Production.
Iino C; Shimoyama T; Iino K; Yokoyama Y; Chinda D; Sakuraba H; Fukuda S; Nakaji S
Nutrients; 2019 Feb; 11(2):. PubMed ID: 30791484
[TBL] [Abstract][Full Text] [Related]
11. Whole soy, but not purified daidzein, had a favorable effect on improvement of cardiovascular risks: a 6-month randomized, double-blind, and placebo-controlled trial in equol-producing postmenopausal women.
Liu ZM; Ho SC; Chen YM; Ho S; To K; Tomlinson B; Woo J
Mol Nutr Food Res; 2014 Apr; 58(4):709-17. PubMed ID: 24273218
[TBL] [Abstract][Full Text] [Related]
12. Use of Physiologically Based Kinetic Modeling to Predict Rat Gut Microbial Metabolism of the Isoflavone Daidzein to S-Equol and Its Consequences for ERα Activation.
Wang Q; Spenkelink B; Boonpawa R; Rietjens IMCM; Beekmann K
Mol Nutr Food Res; 2020 Mar; 64(6):e1900912. PubMed ID: 32027771
[TBL] [Abstract][Full Text] [Related]
13. Being overweight or obese is associated with harboring a gut microbial community not capable of metabolizing the soy isoflavone daidzein to O-desmethylangolensin in peri- and post-menopausal women.
Miller LM; Lampe JW; Newton KM; Gundersen G; Fuller S; Reed SD; Frankenfeld CL
Maturitas; 2017 May; 99():37-42. PubMed ID: 28364866
[TBL] [Abstract][Full Text] [Related]
14. The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010).
North American Menopause Society
Menopause; 2011 Jul; 18(7):732-53. PubMed ID: 21685820
[TBL] [Abstract][Full Text] [Related]
15. Soy and Frequent Dairy Consumption with Subsequent Equol Production Reveals Decreased Gut Health in a Cohort of Healthy Puerto Rican Women.
Lacourt-Ventura MY; Vilanova-Cuevas B; Rivera-Rodríguez D; Rosario-Acevedo R; Miranda C; Maldonado-Martínez G; Maysonet J; Vargas D; Ruiz Y; Hunter-Mellado R; Cubano LA; Dharmawardhane S; Lampe JW; Baerga-Ortiz A; Godoy-Vitorino F; Martínez-Montemayor MM
Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444002
[TBL] [Abstract][Full Text] [Related]
16. Is equol the key to the efficacy of soy foods?
Lampe JW
Am J Clin Nutr; 2009 May; 89(5):1664S-1667S. PubMed ID: 19357217
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of dietary soy isoflavones to equol by human intestinal microflora--implications for health.
Yuan JP; Wang JH; Liu X
Mol Nutr Food Res; 2007 Jul; 51(7):765-81. PubMed ID: 17579894
[TBL] [Abstract][Full Text] [Related]
18. Randomized controlled trial of whole soy and isoflavone daidzein on menopausal symptoms in equol-producing Chinese postmenopausal women.
Liu ZM; Ho SC; Woo J; Chen YM; Wong C
Menopause; 2014 Jun; 21(6):653-60. PubMed ID: 24149925
[TBL] [Abstract][Full Text] [Related]
19. Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein.
Frankenfeld CL; Atkinson C; Wähälä K; Lampe JW
Eur J Clin Nutr; 2014 Apr; 68(4):526-30. PubMed ID: 24569543
[TBL] [Abstract][Full Text] [Related]
20. Research protocol: effect of natural S-equol on blood pressure and vascular function--a six-month randomized controlled trial among equol non-producers of postmenopausal women with prehypertension or untreated stage 1 hypertension.
Liu ZM; Ho SC; Chen YM; Xie YJ; Huang ZG; Ling WH
BMC Complement Altern Med; 2016 Mar; 16():89. PubMed ID: 26928904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
